BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15605208)

  • 1. Practical approach to the therapy of systemic sclerosis.
    Czirják L
    Z Rheumatol; 2004 Dec; 63(6):451-6. PubMed ID: 15605208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
    Lin AT; Clements PJ; Furst DE
    Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of DMARDs in systemic sclerosis therapy.
    Blank N; Max R; Lorenz HM
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii42-4. PubMed ID: 16987834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis: Recent insights.
    Elhai M; Avouac J; Kahan A; Allanore Y
    Joint Bone Spine; 2015 May; 82(3):148-53. PubMed ID: 25557659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of agents for the treatment of systemic sclerosis.
    Herrick AL
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1255-64. PubMed ID: 11772249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old medications and new targeted therapies in systemic sclerosis.
    Nagaraja V; Denton CP; Khanna D
    Rheumatology (Oxford); 2015 Nov; 54(11):1944-53. PubMed ID: 25065013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.
    White B; Bauer EA; Goldsmith LA; Hochberg MC; Katz LM; Korn JH; Lachenbruch PA; LeRoy EC; Mitrane MP; Paulus HE
    Arthritis Rheum; 1995 Mar; 38(3):351-60. PubMed ID: 7880189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence-based therapy of systemic sclerosis].
    Genth E
    Z Rheumatol; 2001 Dec; 60(6):464-8. PubMed ID: 11826742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis. Current classification and diagnosis of organ involvement].
    Persa OD; Moinzadeh P; Hunzelmann N
    Hautarzt; 2015 Aug; 66(8):599-603. PubMed ID: 26115973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis refractory disease: from the skin to the heart.
    Almeida I; Faria R; Vita P; Vasconcelos C
    Autoimmun Rev; 2011 Sep; 10(11):693-701. PubMed ID: 21575745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.
    Bellando-Randone S; Matucci-Cerinic M
    Curr Rheumatol Rep; 2017 Sep; 19(10):65. PubMed ID: 28921059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
    Radić M; Kaliterna DM; Fabijanić D; Radić J
    Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials for the treatment of systemic sclerosis/scleroderma.
    Varga J; Ponor I
    Curr Rheumatol Rep; 1999 Oct; 1(1):13-4. PubMed ID: 11123008
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group.
    Airò P; Rossi M; Scarsi M; Danieli E; Grottolo A; Zambruni A
    Clin Exp Rheumatol; 2007; 25(5):722-7. PubMed ID: 18078620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis: hypothesis-driven treatment strategies.
    Charles C; Clements P; Furst DE
    Lancet; 2006 May; 367(9523):1683-91. PubMed ID: 16714190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.